ID   DNM3L_HUMAN             Reviewed;         386 AA.
AC   Q9UJW3; E9PB42; Q9BUJ4;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 3.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=DNA (cytosine-5)-methyltransferase 3-like;
GN   Name=DNMT3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10857753; DOI=10.1006/geno.2000.6168;
RA   Aapola U., Shibuya K., Scott H.S., Ollila J., Vihinen M., Heino M.,
RA   Shintani A., Kawasaki K., Minoshima S., Krohn K., Antonarakis S.E.,
RA   Shimizu N., Kudoh J., Peterson P.;
RT   "Isolation and initial characterization of a novel zinc finger gene,
RT   DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene
RT   family.";
RL   Genomics 65:293-298(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-278.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS), FUNCTION, AND HOMODIMERIZATION.
RX   PubMed=17687327; DOI=10.1038/nature05987;
RA   Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z.,
RA   Erdjument-Bromage H., Tempst P., Lin S.-P., Allis C.D., Cheng X.,
RA   Bestor T.H.;
RT   "DNMT3L connects unmethylated lysine 4 of histone H3 to de novo
RT   methylation of DNA.";
RL   Nature 448:714-717(2007).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.89 ANGSTROMS) OF 160-387, SUBUNIT, AND
RP   MUTAGENESIS OF PHE-261.
RX   PubMed=17713477; DOI=10.1038/nature06146;
RA   Jia D., Jurkowska R.Z., Zhang X., Jeltsch A., Cheng X.;
RT   "Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA
RT   methylation.";
RL   Nature 449:248-251(2007).
CC   -!- FUNCTION: Catalytically inactive regulatory factor of DNA
CC       methyltransferases that can either promote or inhibit DNA
CC       methylation depending on the context (By similarity). Essential
CC       for the function of DNMT3A and DNMT3B: activates DNMT3A and DNMT3B
CC       by binding to their catalytic domain (PubMed:17687327). Acts by
CC       accelerating the binding of DNA and S-adenosyl-L-methionine
CC       (AdoMet) to the methyltransferases and dissociates from the
CC       complex after DNA binding to the methyltransferases
CC       (PubMed:17687327). Recognizes unmethylated histone H3 lysine 4
CC       (H3K4me0) and induces de novo DNA methylation by recruitment or
CC       activation of DNMT3 (PubMed:17687327). Plays a key role in
CC       embryonic stem cells and germ cells (By similarity). In germ
CC       cells, required for the methylation of imprinted loci together
CC       with DNMT3A (By similarity). In male germ cells, specifically
CC       required to methylate retrotransposons, preventing their
CC       mobilization (By similarity). Plays a key role in embryonic stem
CC       cells (ESCs) by acting both as an positive and negative regulator
CC       of DNA methylation (By similarity). While it promotes DNA
CC       methylation of housekeeping genes together with DNMT3A and DNMT3B,
CC       it also acts as an inhibitor of DNA methylation at the promoter of
CC       bivalent genes (By similarity). Interacts with the EZH2 component
CC       of the PRC2/EED-EZH2 complex, preventing interaction of DNMT3A and
CC       DNMT3B with the PRC2/EED-EZH2 complex, leading to maintain low
CC       methylation levels at the promoters of bivalent genes (By
CC       similarity). Promotes differentiation of ESCs into primordial germ
CC       cells by inhibiting DNA methylation at the promoter of RHOX5,
CC       thereby activating its expression (By similarity).
CC       {ECO:0000250|UniProtKB:Q9CWR8, ECO:0000269|PubMed:17687327}.
CC   -!- SUBUNIT: Homodimer (PubMed:17687327, PubMed:17713477).
CC       Heterotetramer composed of 1 DNMT3A homodimer and 2 DNMT3L
CC       subunits (DNMT3L-DNMT3A-DNMT3A-DNMT3L) (PubMed:17713477).
CC       Interacts with histone H3 (via N-terminus); interaction is
CC       strongly inhibited by methylation at lysine 4 (H3K4me)
CC       (PubMed:17687327). Interacts with EZH2; the interaction is direct
CC       (By similarity). {ECO:0000250|UniProtKB:Q9CWR8,
CC       ECO:0000269|PubMed:17687327, ECO:0000269|PubMed:17713477}.
CC   -!- INTERACTION:
CC       Q13547:HDAC1; NbExp=3; IntAct=EBI-740967, EBI-301834;
CC       Q9UHA3:RSL24D1; NbExp=6; IntAct=EBI-740967, EBI-749321;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Other splice isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9UJW3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJW3-2; Sequence=VSP_041295;
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in several tissues
CC       including testis, ovary, and thymus.
CC       {ECO:0000269|PubMed:10857753}.
CC   -!- MISCELLANEOUS: Interaction with histone H3 is strongly inhibited
CC       by methylation at lysine 4 (H3K4me).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF194032; AAF05812.1; -; mRNA.
DR   EMBL; AP001753; BAA95556.1; -; Genomic_DNA.
DR   EMBL; AP001059; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001060; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09445.1; -; Genomic_DNA.
DR   EMBL; BC002560; AAH02560.1; -; mRNA.
DR   CCDS; CCDS13705.1; -. [Q9UJW3-2]
DR   CCDS; CCDS46650.1; -. [Q9UJW3-1]
DR   RefSeq; NP_037501.2; NM_013369.3. [Q9UJW3-2]
DR   RefSeq; NP_787063.1; NM_175867.2. [Q9UJW3-1]
DR   UniGene; Hs.592165; -.
DR   PDB; 2PV0; X-ray; 3.30 A; A/B/C=1-386.
DR   PDB; 2PVC; X-ray; 3.69 A; A/B/C=1-386.
DR   PDB; 2QRV; X-ray; 2.89 A; B/C/F/G=160-386.
DR   PDB; 4U7P; X-ray; 3.82 A; B=178-379.
DR   PDB; 4U7T; X-ray; 2.90 A; B/D=178-379.
DR   PDBsum; 2PV0; -.
DR   PDBsum; 2PVC; -.
DR   PDBsum; 2QRV; -.
DR   PDBsum; 4U7P; -.
DR   PDBsum; 4U7T; -.
DR   ProteinModelPortal; Q9UJW3; -.
DR   SMR; Q9UJW3; -.
DR   BioGrid; 118984; 81.
DR   DIP; DIP-35238N; -.
DR   IntAct; Q9UJW3; 8.
DR   MINT; MINT-1448248; -.
DR   STRING; 9606.ENSP00000270172; -.
DR   BindingDB; Q9UJW3; -.
DR   ChEMBL; CHEMBL3137291; -.
DR   REBASE; 4636; M.HsaDnmt3L.
DR   iPTMnet; Q9UJW3; -.
DR   PhosphoSitePlus; Q9UJW3; -.
DR   BioMuta; DNMT3L; -.
DR   DMDM; 334302913; -.
DR   EPD; Q9UJW3; -.
DR   PaxDb; Q9UJW3; -.
DR   PRIDE; Q9UJW3; -.
DR   DNASU; 29947; -.
DR   Ensembl; ENST00000270172; ENSP00000270172; ENSG00000142182. [Q9UJW3-2]
DR   Ensembl; ENST00000628202; ENSP00000486001; ENSG00000142182. [Q9UJW3-1]
DR   GeneID; 29947; -.
DR   KEGG; hsa:29947; -.
DR   UCSC; uc002zeg.3; human. [Q9UJW3-1]
DR   CTD; 29947; -.
DR   DisGeNET; 29947; -.
DR   GeneCards; DNMT3L; -.
DR   HGNC; HGNC:2980; DNMT3L.
DR   HPA; HPA055234; -.
DR   HPA; HPA066780; -.
DR   MIM; 606588; gene.
DR   neXtProt; NX_Q9UJW3; -.
DR   OpenTargets; ENSG00000142182; -.
DR   PharmGKB; PA27447; -.
DR   eggNOG; ENOG410IIXK; Eukaryota.
DR   eggNOG; ENOG4111C55; LUCA.
DR   GeneTree; ENSGT00390000008341; -.
DR   HOGENOM; HOG000246422; -.
DR   HOVERGEN; HBG051382; -.
DR   InParanoid; Q9UJW3; -.
DR   KO; K17400; -.
DR   OMA; TVPVWKR; -.
DR   OrthoDB; EOG091G08YY; -.
DR   TreeFam; TF329039; -.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   ChiTaRS; DNMT3L; human.
DR   EvolutionaryTrace; Q9UJW3; -.
DR   GeneWiki; DNMT3L; -.
DR   GenomeRNAi; 29947; -.
DR   PRO; PR:Q9UJW3; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000142182; -.
DR   CleanEx; HS_DNMT3L; -.
DR   ExpressionAtlas; Q9UJW3; baseline and differential.
DR   Genevisible; Q9UJW3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008047; F:enzyme activator activity; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006306; P:DNA methylation; NAS:UniProtKB.
DR   GO; GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB.
DR   GO; GO:0032776; P:DNA methylation on cytosine; ISS:UniProtKB.
DR   GO; GO:0007141; P:male meiosis I; ISS:UniProtKB.
DR   GO; GO:1905642; P:negative regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:1905643; P:positive regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; NAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0048863; P:stem cell differentiation; ISS:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR025766; ADD.
DR   InterPro; IPR030486; DNMT3L.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR23068:SF15; PTHR23068:SF15; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51533; ADD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Differentiation; Metal-binding; Nucleus; Polymorphism;
KW   Reference proteome; Spermatogenesis; Zinc; Zinc-finger.
FT   CHAIN         1    386       DNA (cytosine-5)-methyltransferase 3-
FT                                like.
FT                                /FTId=PRO_0000088047.
FT   DOMAIN       41    173       ADD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00865}.
FT   ZN_FING      52     82       GATA-type; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00865}.
FT   ZN_FING      93    149       PHD-type; atypical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00865}.
FT   VAR_SEQ     332    332       S -> SS (in isoform 2).
FT                                {ECO:0000303|PubMed:10857753}.
FT                                /FTId=VSP_041295.
FT   VARIANT     278    278       R -> G (in dbSNP:rs7354779).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_051962.
FT   MUTAGEN     261    261       F->A: Loss of binding to DNMT3A.
FT                                {ECO:0000269|PubMed:17713477}.
FT   CONFLICT    246    246       P -> A (in Ref. 1; AAF05812).
FT                                {ECO:0000305}.
FT   CONFLICT    266    266       L -> F (in Ref. 1; AAF05812).
FT                                {ECO:0000305}.
FT   HELIX        35     43       {ECO:0000244|PDB:2PV0}.
FT   HELIX        49     51       {ECO:0000244|PDB:2PV0}.
FT   TURN         54     56       {ECO:0000244|PDB:2PV0}.
FT   STRAND       66     71       {ECO:0000244|PDB:2PV0}.
FT   HELIX        74     81       {ECO:0000244|PDB:2PV0}.
FT   TURN         82     85       {ECO:0000244|PDB:2PV0}.
FT   STRAND       89     93       {ECO:0000244|PDB:2PV0}.
FT   TURN         97     99       {ECO:0000244|PDB:2PV0}.
FT   HELIX       119    125       {ECO:0000244|PDB:2PV0}.
FT   HELIX       130    136       {ECO:0000244|PDB:2PV0}.
FT   TURN        143    145       {ECO:0000244|PDB:2PV0}.
FT   STRAND      154    156       {ECO:0000244|PDB:2PV0}.
FT   HELIX       160    171       {ECO:0000244|PDB:2PV0}.
FT   HELIX       184    186       {ECO:0000244|PDB:2QRV}.
FT   STRAND      192    197       {ECO:0000244|PDB:2QRV}.
FT   TURN        200    207       {ECO:0000244|PDB:2QRV}.
FT   STRAND      218    222       {ECO:0000244|PDB:2QRV}.
FT   HELIX       224    226       {ECO:0000244|PDB:4U7T}.
FT   HELIX       229    234       {ECO:0000244|PDB:2QRV}.
FT   STRAND      239    244       {ECO:0000244|PDB:2QRV}.
FT   TURN        248    250       {ECO:0000244|PDB:2QRV}.
FT   HELIX       257    270       {ECO:0000244|PDB:2QRV}.
FT   STRAND      281    286       {ECO:0000244|PDB:2QRV}.
FT   HELIX       292    302       {ECO:0000244|PDB:2QRV}.
FT   STRAND      308    310       {ECO:0000244|PDB:2PV0}.
FT   STRAND      314    316       {ECO:0000244|PDB:2PV0}.
FT   STRAND      322    325       {ECO:0000244|PDB:2QRV}.
FT   STRAND      327    331       {ECO:0000244|PDB:2PV0}.
FT   HELIX       340    351       {ECO:0000244|PDB:2QRV}.
FT   HELIX       362    365       {ECO:0000244|PDB:2QRV}.
FT   HELIX       369    373       {ECO:0000244|PDB:2QRV}.
SQ   SEQUENCE   386 AA;  43583 MW;  65EC2AB7492D53B3 CRC64;
     MAAIPALDPE AEPSMDVILV GSSELSSSVS PGTGRDLIAY EVKANQRNIE DICICCGSLQ
     VHTQHPLFEG GICAPCKDKF LDALFLYDDD GYQSYCSICC SGETLLICGN PDCTRCYCFE
     CVDSLVGPGT SGKVHAMSNW VCYLCLPSSR SGLLQRRRKW RSQLKAFYDR ESENPLEMFE
     TVPVWRRQPV RVLSLFEDIK KELTSLGFLE SGSDPGQLKH VVDVTDTVRK DVEEWGPFDL
     VYGATPPLGH TCDRPPSWYL FQFHRLLQYA RPKPGSPRPF FWMFVDNLVL NKEDLDVASR
     FLEMEPVTIP DVHGGSLQNA VRVWSNIPAI RSRHWALVSE EELSLLAQNK QSSKLAAKWP
     TKLVKNCFLP LREYFKYFST ELTSSL
//
